Sub-Saharan Africa (SSA) Pharmaceuticals Market Set to Reach USD 13 Billion by 2030
The Sub-Saharan Africa (SSA) pharmaceuticals market is entering a pivotal growth phase, projected to expand from USD 8 billion in 2025 to nearly USD 13 billion by 2030, registering a robust CAGR of 10.2%, according to a comprehensive new market study. This surge is attributed to ongoing epidemiological transitions, international aid, expanding health insurance coverage, […]
Continue Reading